The autolytic enzyme (an N-acetylmuramyl-L-alanine amidase) of a clinical isolate, strain 101/87, which is classified as an atypical pneumococcus, has been studied for the first time. The lytA4101 gene coding for this amidase (LYTA101) has been cloned, sequenced, and expressed in Escherichia coli. The LYTA101 amidase has been purified and shown to be similar to the main autolytic enzyme (LYTA) present in the wild-type strain of Streptococcus pneumoniae, although it exhibits a lower specific activity, a higher sensitivity to inhibition by free choline, and a modified thermosensitivity with respect to LYTA. Most important, in contrast with the LYTA amidase, the activity of the LYTA101 amidase was inhibited by sodium deoxycholate. This property is most probably responsible of the deoxycholate-insensitive phenotype shown by strain 101/87. Phenotypic curing of strain 101/87 by externally adding purified LYTA or LYTA101 amidase restored in this strain some typical characteristics of the wild-type strain of pneumococcus (e.g., formation of diplo cells and sensitization to lysis by sodium deoxycholate), although the amount of the LYTA101 amidase required to restore these properties was much higher than in the case of the LYTA amidase. Our results indicate that modifications in the primary structure or in the mechanisms that control the activity of cell wall lytic enzymes seem to be responsible for the characteristics exhibited by some strains of S. pneumoniae that have been classically misclassified and should be now considered atypical pneumococcal strains.
be now considered atypical pneumococcal strains.
The recent development of DNA probes for the rapid and reliable identification of Streptococcus pneumoniae from clinical specimens has facilitated the recognition of pneumococcal isolates showing atypical responses in conventional identification tests (11, 28) . One of the best-documented examples of such behavior is the sensitivity of pneumococci to bile (deoxycholate [DOC]-sensitive [DOC'] phenotype), which is considered a distinctive characteristic of this species (24) . It has been demonstrated that there are laboratory pneumococcal strains for which the atypical responses to this test can be easily ascribed to a genetic defect, the most common being DOC-mutants designated LYTA-, i.e., lacking the main autolytic enzyme (an N-acetylmuramyl-Lalanine amidase designated the LYTA amidase) characteristic of this species (20, 23, 34) .
We report here the characterization of the autolytic enzyme of a clinical isolate, strain 101/87, that has been identified as an atypical pneumococcus on the basis of the use of highly specific DNA probes. Strain 101/87 apparently contains a normal level of active autolytic amidase, although it is not bile sensitive, a phenomenon classically considered autolysin dependent (26) . Detailed study of the autolytic system of pneumococcal clinical isolates like the one reported here, using recently developed molecular tools (6-9, 12-16, 23, 29-32, 34) , should contribute to a better knowledge of the factor(s) that leads to the appearance of more sophisticated phenotypes of atypical pneumococcal strains in nature and should help to develop strategies for dealing with such varieties of pathogenic strains. In addition, the availability of such mutants can provide new ways to study the molecular mechanisms that regulate the activity of the autolytic enzymes as well as the evolution of the genes coding for these enzymes since, to the best of our knowl-* Corresponding author. edge, this is the first time that the autolysin of a clinical isolate of S. pneumoniae has been studied at a molecular level.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The Escherichia coli strains used were HB101 [F-hsdS20 (rB-mB-) recA13 ara-14 proA2 leuB lacYl galK2 rpsL20 xylS mtl-l supE44] (33), C600 (F-thi-1 leuB6 thr-1 lacY6 tonA21 supE44) (33) , and JM83 [A(lac-proAB) ara rpsL +80 lacZ AM15] (25) . S. pneumoniae strains used were wild-type R6 (Rockefeller University), M31 (AlytA) (34) , and 101/87 (11) . Plasmids used were pUC19 (Apr) (25) , pGL30 (lytA Apr) (13) , and pED1 (lytA Tcr) (7) . E. coli C600 or S. pneumoniae M31 was used as the host for pED1 and derivative plasmids. E. coli was grown in LB medium (33) at 37°C with shaking, and S. pneumoniae was grown in C medium (38) supplemented with yeast extract (0.8 mg/ml; Difco Laboratories) (C + Y medium) or in Cden-EA medium (41) at 37°C without shaking. Growth of S. pneumoniae was monitored with a Coleman nephelometer.
Plasmid isolation and transformation. Plasmid DNA was prepared by the rapid alkaline method (2) . Transformation of E. coli was carried out by using the RbCl method (33) . Transformation of competent cells of S. pneumoniae was performed according to a procedure previously described (38) .
DNA sequence analysis. DNA sequencing was carried out by the dideoxy-chain termination method (35) , using the Sequenase kit from United States Biochemical. Oligonucleotide primers were synthesized in a Pharmacia LKB Gene Assembler Plus DNA synthesizer.
Purification of enzymes. The LYTA101 amidase was purified from extracts of E. coli HB101(pNH101) (see below) by affinity chromatography on DEAE-cellulose, using the sin-gle-step procedure described elsewhere (36) . The apparent Mrs of the enzymes were determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) according to Laemmli (21) .
Assay for cell wall lytic activity. (14, 39) .
Immunoblot and Southern blot analyses. Immunoblots were carried out by using anti-pneumococcal amidase serum as described previously (30) . Extracts were electrophoresed on SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher & Schuell). After incubation with the primary antiamidase serum, the blots were incubated with a peroxidase-conjugated AffiniPure goat antirabbit serum (Jackson Immunoresearch), and the protein bands were visualized by using 4-chloro-1-naphthol (Sigma). Southern blot analyses were carried out by using radioactive probes labeled by the random-primer method in the presence of [a-32P]dCTP (33) .
DOC-induced lysis of pneumococcal cells. Susceptibility of the bacteria to sodium DOC or Triton X-100 was tested as previously described (41) . In short, 1-ml portions of a culture in the exponential phase of growth were pipetted into test tubes containing 0.1 ml of 1 M sodium phosphate buffer (pH 8.0). After the initial light-scattering value of the suspension was recorded, 0.1 ml of a 10% sodium DOC or Triton X-100 solution was added, the suspension was incubated at 37°C for 5 min, and the light scattering of the treated suspension was recorded again. Sensitization to externally added autolytic enzyme. Sensitization to externally added lytic amidase was tested as previously described (40 It had been demonstrated that DOC stimulated the cell wall lytic activity of the pneumococcal amidase when added to crude extracts of wild-type strain R6 (3). This result was ascribed to the release of the inhibitory effect produced by the choline-containing lipoteichoic acid (LTA) (3). In contrast with this behavior, we found that DOC inhibited the lytic activity contained in crude extracts of strain 101/87 and that other detergents, such as Brij 58 and Triton X-100, stimulated the lytic activities of strains 101/87 and R6 (data not shown). Hence, it was not surprising that the use of Triton X-100 instead of DOC immediately induced the lysis of cultures of strain 101/87.
The data presented above demonstrated the presence in strain 101/87 of a lytic enzyme similar, but apparently not identical, to that of the LYTA amidase present in wild-type strain R6 (15) . We speculated that differences at the level of the primary structures between the two enzymes might account for the inhibitory effect of DOC and the altered characteristics of the pneumococcal strain described in this report. Hence, we decided to clone, sequence, and express the gene encoding the autolytic enzyme of strain 101/87 in E. coli.
Cloning and expression in E. coli of the lytA101 gene of S. pneumoniae 101/87. Since the DNA from strain 101/87 hybridized with the lytA gene used as a specific pneumococcal probe in dot blot hybridization experiments (11) , and given that the complete structural lytA gene coding for the pneumococcal amidase of the wild-type strain had been localized to a 1.2-kb HindIII fragment (15), we constructed in E. coli JM83 a HindIII library with the DNA of strain 101/87, using pUC19 as the vector. A clone containing a plasmid of 4.4-kb was isolated from this library by using the lytA gene as a probe. The plasmid, designated pNH101, was used to transform E. coli HB101, and crude extracts obtained from one of the transformants, E. coli HB101(pNH101), exhibited lytic activity when tested on choline-containing pneumococcal cell walls in an in vitro assay, suggesting that the cloned fragment contained the lytA101 gene coding for the autolytic enzyme of S. pneumoniae 101/87. It is interesting that the enzyme responsible for this activity requires the process of conversion to achieve full enzymatic activity, as reported for the pneumococcal host and phage amidases described so far (3, 17, 29, 36) . It was observed that the primary translation product of the lyjA gene, an inactive form of the pneumococcal amidase (E form), can be converted to the active C form in the presence of choline-containing cell walls or 2% free choline (3, 36) .
Nucleotide sequence analysis of the lytA101 gene. Remarkably, the size of plasmid pNH101 indicated that the lytA101 gene was contained in a 1.7-kb HindIII fragment, in contrast to the lytA gene, which was localized to a 1.2-kb HindlIl fragment (15) . The nucleotide sequence of the 1.7-kb HindIII fragment present in plasmid pNH101 is shown in Fig. 2 . The lytA101 gene codes for a protein (LYTA101) of 316 amino acids with a deduced Mr of 36,472. As expected, the LYTA101 enzyme shows a modular organization similar to that previously reported for the lytic enzymes of S. pneumoniae and its bacteriophages, i.e., an N-terminal domain responsible for the specific enzymatic activity and a C-terminal domain containing a set of six repeated sequences or motifs (P1 to P6) that should be involved in the recognition of the cell wall substrate (8, 9, 12, 16 (Fig. 4C) , digested with HindIII, EcoRI, AccI or PvuII, and probed with a 0.35-kb DraI-HindIII fragment of plasmid pNH101, a fragment that is located 197 bp downstream from the termination codon of the lytA101 gene, allowed us to determine the existence of a 1-to 2.1-kb-long deletion in the vicinity of the termination codon of the lytA101 gene (Fig. 4D) , affecting the hairpin that participates in termination of the transcript of the lytA gene (7) .
Purification and biochemical characterization of the LYTA101 protein. We purify the lytic activity present in extracts obtained from E. coli HB101(pNH101) in a single step, using DEAE-cellulose (36) . The LYTA101 enzyme is slightly lower in mobility than the LYTA wild-type amidase (Fig. 1B) , as observed for the crude extracts of strain 101/87 (Fig. 1A) ; this mobility corresponds to an apparent Mr of 37,500, slightly higher than that deduced from the amino acid sequence. Table 1 summarizes the most relevant biochemical properties of the LYTA101 enzyme. Analyses of the soluble degradation products of pneumococcal cell walls radioactively labeled with either choline or lysine indicated that this enzyme is an N-acetylmuramyl-L-alanine amidase (data not shown). The purified enzyme can degrade cell walls containing choline but not ethanolamine, indicating that it is a choline-dependent enzyme. DOC inhibited the activity of the enzyme, as found when crude extracts containing LYTA101 were tested in vitro. However, DOC does not alter the activity of the purified wild-type LYTA enzyme, since LTA is not present in the assay. Triton X-100 did not change the activities of the purified LYTA or LYTA101 amidase. Free choline, a noncompetitive inhibitor of pneumococcal lytic enzymes (3, 14, 16, 17, 29) , inhibited about 50% of the activity of the LYTA101 amidase at a concentration of 7 mM, lower than that required to inhibit the LYTA amidase (24 mM). This characteristic was reminiscent of that of the CPL1 lysozyme encoded by the pneumococcal phage Cp-1; 3 mM choline was sufficient to inhibit 50% of this lysozyme activity (8) . The specific activity of the purified LYTA101 amidase was lower than that of the LYTA amidase. In addition, the LYTA101 amidase appeared to be more unstable than the LYTA amidase, as judged by its lower thermostability at 37°C. Although both LYTA101 and LYTA amidases showed an optimal pH of 6.5, the former was three times less active than the latter when assayed at an alkaline pH, a fact that should be considered if the clinical DOC assay used to identify pneumococcal strains is performed at pH 8.0. Biological test of the LYTA101 amidase. The purified LYTA101 amidase was also tested for its capacity to restore in strain M31, a pneumococcal mutant that is deleted of the lytA gene, a series of biological and biochemical properties pertinent to the wild-type amidase (LYTA). We have found that addition of 300 U of the LYTA101 or LYTA amidase per ml to the growth medium for strain M31 makes these cells lyse at the end of the exponential phase of growth when incubated at 37°C as a result of the phenotypic curing (40) achieved by M31, which leads to a behavior that mimics the spontaneous lysis found for wild-type strain R6 at the end of the exponential phase of growth. However, sensitization to DOC required the addition of much higher amounts of purified LYTA101 amidase (1,200 U/ml), in contrast with the situation found when the enzyme treatment was carried out with the wild-type LYTA amidase, in which case the addition of 300 U/ml restored the characteristic DOC' phenotype characteristic of the wild-type strain. Furthermore, addition of either the LYTA or LYTA101 amidase was able to restore in strain 101/87 those properties formerly associated with the amidase (chaining disappears and cells are lysed by DOC), although the amount of LYTA101 amidase required to restore these properties to strain 101/87 was again much higher than in the case of the LYTA amidase. The fact that strain 101/87 returned to a typical diplo morphology when it was phenotypically cured with either amidase also confirmed that we were dealing with true pneumococcal cells.
Cloning of the lytA4101 gene in S. pneumoniae. To test in a a Although the two enzymes had the same optimal pH (6.5), the residual activity of the LYTA101 amidase choline-containing cell walls at pH 8.0 was 16%, whereas the LYTA amidase retained 45% of activity. However, the residual activity of the LYTA101 amidase at pH 5.5 was 84%, whereas the activity of the LYTA amidase was 55%. Both enzymes exhibited conversion by choline. Conversion was determined by using crude extracts of E. coli recombinants expressing the LYTA101 or LYTA amidase after 5 min of preincubation at 0'C with choline-containing cell walls or 2% choline chloride, since the purified enzymes were converted after elution from DEAE-cellulose with 2% choline (36) .
b Both enzymes had activity of <1 U/mg on ethanolamine-containing cell walls.
c Both enzymes showed 100% activity after treatment with 0.1% Triton X-100. direct experimental way the assumption that a high level of LYTA101 activity can restore the DOC' phenotype, we decided to clone the lytA101 gene in S. pneumoniae M31. To do this, we placed this gene under the control of the lytA promoter in a plasmid adapted to pneumococcus, using a strategy previously reported (7), to create plasmid pED4 (not shown). Competent cells of strain M31 were transformed with pED4, and one of the tetracycline-resistant transformants was identified as S. pneumoniae M31(pED4). When this strain was cultured in C + Y medium, the cells grew at a normal rate, although they lysed rapidly at the end of the exponential phase of growth, in contrast with the noticeable stationary phase normally found in wild-type strain R6 (Fig.  5 ). This characteristic can be ascribed to a high level of amidase activity due to the presence of several copies of plasmid pED4, as previously reported for M31 transformed with similar high-copy-number plasmids containing the lytA gene (7, 31, 32) . In fact, we found that crude extracts from S. (20, 23, 26, 31, 34) . However, the mechanistic basis of the morphological characteristics and the DOC-phenotype of the clinical isolate, strain 101/87, could not be associated merely with the absence or low level of amidase activity in crude extracts of this strain. Although extracts from strain 101/87 contained an autolytic activity lower than that present in wild-type strain R6, this reduced activity was far above that of other pneumococcal strains which exhibited a DOC' phenotype but had an autolytic activity much lower than that found in R6 (22) . On the other hand, the observation that the LYTA and LYTA101 amidases were able to reestablish the normal diplo morphology in cultures of strain 101/87 strongly indicated that this strain has a normal choline-containing cell wall.
However, the finding that the lytic activity present in crude extracts from strain 101/87 was inhibited by DOC rather than stimulated, as occurs in wild-type strain R6 ( Table 1) , indicated that the DOC-phenotype was correlated with the atypical inhibition of the LYTA101 amidase by DOC. Interestingly, the effect of DOC could be ascribed to an intrinsic property of the LYTA101 amidase, since DOC inhibition was also observed for the purified enzyme (Table 1) . Moreover, given that the lytic activity of the LYTA101 amidase was considerably reduced at pH 8.0, it seems reasonable to assume that the enzymatic level required to induce cell lysis was not achieved in the presence of DOC at pH 8.0.
Biochemical studies and biological tests for phenotypic curing of mutant M31 performed with the purified LYTA101 amidase suggest that in addition to the effects of DOC and pH, other properties of this amidase, i.e., its lower specific activity and lower thermostability, render this enzyme less efficient than the LYTA amidase. In turn, these properties could also contribute to the phenotypic characteristics exhibited by strain 101/87 and help to explain why amounts of the LYTA101 amidase higher than those of the wild-type LYTA amidase were required to restore the sensitivity of strains M31 and 101/87 to lysis by DOC when the enzymes were exogenously added. This conclusion was reinforced by the observation that the presence in M31(pED4) of several copies of the lytA101 gene, expressing higher amounts of the LYTA101 amidase, reintroduced sensitivity to DOC (Fig. 5) .
Nevertheless, we cannot rule out the possibility that the DOC-phenotype and the long-chain morphology of strain 101/87 might be consequences of a lysis-defective mechanism that could involve some aspects of autolysin control due to an alteration in the pathway that triggers the amidase. It appears reasonable to consider that the structural changes observed in the LYTA101 amidase might generate a stronger atypical interaction of the enzyme with the components of the cell envelope that seem to regulate its activity (membrane, LTA, etc.) (6) . This interaction could prevent an adequate level of lytic activity from reaching the cell wall substrate when cells are growing normally as well as in the presence of DOC. Two observations appear to support this assumption: (i) the fact that the nonionic detergent Triton X-100 was able to induce the lysis of strain 101/87, probably because of a more efficient release of the LYTA101 enzyme than of DOC from the cellular envelope, as deduced from the stimulating effect of Triton X-100 on the lytic activity determined in crude extracts (Table 1) , and (ii) the finding that the LYTA101 amidase was more sensitive to the inhibition by free choline than was the LYTA amidase (Table 1) , which may account for the more stable interaction between the LYTA101 amidase and its natural inhibitor, the cholinecontaining LTA present in the pneumococcal membrane.
The sequences of the lytA and lytA101 genes were found to differ by about 19% (Fig. 2) . It has been proposed that some essential genes, like the lytic genes, have arisen in phages from host genes (4), and recombination between genes coding for cell wall lytic enzymes of phages and bacteria in S. pneumoniae has been demonstrated in the laboratory (30) . This recombination was facilitated by the close relationship between these genes, which exhibit the highest similarity described so far between phages and bacteria (88% base identity) (30) . This type of genetic event might be the mechanism for introducing diversity in the genes coding for lytic enzymes in pneumococci. The observation that most pathogenic strains isolated from pediatric populations yielded phages when induced by mitomycin (1), as in the case reported in the accompanying report (10) , is very suggestive in this respect. Furthermore, some differences between the lytA4101 and 1ytA genes, such as a deletion of six nucleotides in the P6 motif of the lytA4101 gene, have been found (Fig. 4) ; interestingly, the CPL1 lysozyme encoded by the pneumococcal bacteriophage Cp-1, which also shows a deletion of six nucleotides in the P6 motif of the cpl-1 gene, shares with the LYTA101 amidase a high sensitivity to inhibition of activity by low concentrations of choline (8) . The sum of alterations found in the coding sequence of the lytA101 gene with respect to the wild-type lyt4 gene might account for the structural changes responsible for the biochemical properties of the LYTA101 amidase pointed out above.
In contrast to the relatively high divergence (19%) observed between the structural regions of the lytA and lytA101 genes, the 5'-end flanking regions of these genes, encompassing the leader sequence previously reported for the lytA gene (7), remain quite similar (6% divergence). The fact that the lytA and lytA101 genes differ completely in the region downstream from the termination codon affecting the hairpin found in the 1ytA gene, which functions as a transcription termination site (7), appears to be due to a deletion event tion that this lack of similarity was due to a deletion in this region rather than to an insertion was based on comparative Southern blot hybridizations between the chromosomal DNA from R6 and DNA from plasmid pGL30, using the 0.3-kb DraI-HindIII fragment of plasmid pNH101 as a probe (Fig. 3A) . The Southern blot tests in a fashion similar to that of wild-type strain R6, except in the case of the 1.7-kb HindIII fragment found in the DNA from strain 101/87 (11) . Hence, the regulatory systems of the autolytic enzymes are of interest with respect to both chemotherapy and morphogenesis of bacteria (19) . The findings reported in this communication illustrate how alterations in the activity of the main autolytic enzyme or in its regulation can give rise to dramatic changes affecting the phenotypic characteristics of a clinical isolate of S. pneumoniae and, in turn, might also influence the pathogenic properties of such strains if, as has been recently pointed out (42) , autolysis plays a role in shaping the course of pneumococcal meningitis in vivo, since strains that exhibit alterations in their lytic systems appear to contribute to higher morbidity and mortality from this type of infection. As exemplified in this work, much can be learned from molecular studies of the autolysins of clinical isolates of pneumococci.
